D. Gveric et al., TRANSCRIPTION FACTOR NF-KAPPA-B AND INHIBITOR I-KAPPA-B-ALPHA ARE LOCALIZED IN MACROPHAGES IN ACTIVE MULTIPLE-SCLEROSIS LESIONS, Journal of neuropathology and experimental neurology, 57(2), 1998, pp. 168-178
NF-kappa B is a transcription factor family which on translocation to
the nucleus regulates gene expression during cell activation. As such.
NF-kappa B may play a role in the microglial response to myelin damag
e in multiple sclerosis (MS) lesions. Here the cellular localization o
f NF-kappa B and expression of the inhibitory I kappa B alpha were exa
mined by immunocytochemistry on central nervous system (CNS) tissue fr
om MS? and control cases. In normal control white matter, the active f
orm of the NF-kappa B subunit RelA (p65) was localized in microglial n
uclei, while the c-Rel and p50 subunits and the inhibitory I kappa B a
lpha were restricted to the cytoplasm. In contrast, in actively demyel
inating plaques, the RelA, c-Ret, and p50 subunits of NF-kappa B and I
kappa B alpha were all present in macrophage nuclei in both parenchym
al and perivascular areas. RelA was also found in the nuclei of a subs
et of hypertrophic astrocytes. Only c-Rel had a nuclear localization i
n lymphocytes in perivascular inflammatory cuffs. Our results suggest
that constitutive activation of the RelA subunit in the nuclei of rest
ing microglia may facilitate a rapid response to pathological stimuli
in the CNS. Activation of the inducible NF-kappa B pool in macrophages
in MS lesions could amplify the inflammatory reaction through upregul
ation of NF-kappa B-controlled adhesion molecules and cytokines.